The Effect of Monohydroxyethylrutoside on Doxorubicin-Induced Cardiotoxicity in Patients Treated for Metastatic Cancer in a Phase II Study

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6603994
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pemetrexed for Previously Treated Patients With Metastatic Gastric Cancer: A Prospective Phase II Study

British Journal of Cancer
Cancer ResearchOncology
2014English

The Protective Effect of Cardiac Gene Transfer of CuZn–sod in Comparison With the Cardioprotector Monohydroxyethylrutoside Against Doxorubicin-Induced Cardiotoxicity in Cultured Cells

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2003English

The Protective Effect of Metformin Against Doxorubicin Induced Cardiotoxicity in Rabbits

Al Mustansiriyah Journal of Pharmaceutical Sciences
2019English

Cardioprotective Effect of Marine Astaxanthin on Doxorubicin-Induced Cardiotoxicity in Normal Rats

Journal of Pharmaceutical Research International
2019English

The Role of Nitric Oxide in Doxorubicin-Induced Cardiotoxicity: Experimental Study

Turkish Journal of Haematology
Hematology
2014English

Phase II Study of Docetaxel in Patients With Metastatic Pancreatic Cancer: A Japanese Cooperative Study

British Journal of Cancer
Cancer ResearchOncology
1999English

Phase II Study of Gefitinib, Fluorouracil, Leucovorin, and Oxaliplatin Therapy in Previously Treated Patients With Metastatic Colorectal Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

Long-Term Effects of 7-Monohydroxyethylrutoside (monoHER) on DOX-induced Cardiotoxicity in Mice

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2006English

Neuregulin1-ErbB Signaling in Doxorubicin-Induced Cardiotoxicity

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy